These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34305891)

  • 1. Impact of Sex in the Efficacy of Perioperative Desensitization Procedures in Heart Transplantation: A Retrospective Cohort Study.
    Nguyen LS; Salem JE; Bories MC; Coutance G; Amour J; Bougle A; Suberbielle C; Kheav VD; Carmagnat M; Rouvier P; Kirsch M; Varnous S; Leprince P; Saheb S
    Front Immunol; 2021; 12():659303. PubMed ID: 34305891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable Outcome of an Exclusively Posttransplant Prophylactic Strategy After Heart Transplantation in Recipients With High Immunological Risk.
    Coutance G; d'Orio V; Belin L; Bréchot N; Saheb S; Lebreton G; Bouglé A; Rouvier P; Gautreau C; Ouldammar S; Chamillard X; Huot M; Amour J; Combes A; Leprince P; Varnous S
    Transplantation; 2019 Jul; 103(7):1439-1449. PubMed ID: 30376551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of recipient gender and donor-specific antibodies on antibody-mediated rejection after heart transplantation.
    Nguyen LS; Coutance G; Salem JE; Ouldamar S; Lebreton G; Combes A; Amour J; Laali M; Leprince P; Varnous S
    Am J Transplant; 2019 Apr; 19(4):1160-1167. PubMed ID: 30286278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
    Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.
    Sinangil A; Ucar ZA; Koc Y; Barlas S; Abouzahir S; Ecder ST; Akin EB
    Transplant Proc; 2019 Sep; 51(7):2268-2273. PubMed ID: 31358450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
    Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM
    Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart transplantation across preformed donor-specific antibody barriers using a perioperative desensitization protocol.
    Sommer W; Avsar M; Aburahma K; Salman J; Kaufeld KT; Rojas SV; Meyer AL; Chichelnitskiy E; Süsal C; Kreusser MM; Verboom M; Hallensleben M; Bara C; Blasczyk R; Falk C; Karck M; Haverich A; Ius F; Warnecke G
    Am J Transplant; 2022 Aug; 22(8):2064-2076. PubMed ID: 35426974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Relevance of Posttransplant DSAs in Patients Receiving Desensitization for HLA-incompatible Kidney Transplantation.
    Vo AA; Aubert O; Haas M; Huang E; Zhang X; Choi J; Peng A; Najjar R; Sethi S; Ammerman N; Lim K; Jordan SC
    Transplantation; 2019 Dec; 103(12):2666-2674. PubMed ID: 30883456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study.
    De Sousa-Amorim E; Revuelta I; Blasco M; Diekmann F; Cid J; Lozano M; Sánchez-Escuredo A; Martorell J; Palou E; Campistol JM; Oppenheimer F
    Transplant Proc; 2015 Oct; 47(8):2332-5. PubMed ID: 26518919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
    Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC
    Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Two Preemptive Post-transplant Desensitization Regimens Upon Renal Allograft Survival and DSA Elaboration.
    Kimball PM; McDougan FA; King A
    Clin Transpl; 2014; ():197-203. PubMed ID: 26281145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De Novo Anti-HLA Antibodies After Heart Transplantation Are Associated With Adverse Events in the Long-term Follow-up of Cardiac Transplant Recipients.
    Solé-González E; Mirabet S; Brossa V; López-López L; Rivas-Lasarte M; Capellades-Olivella H; Ginel-Iglesias AJ; Martorell-Pons J; Roig E
    Transplant Proc; 2016 Nov; 48(9):3030-3032. PubMed ID: 27932139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of desensitization protocol with and without rituximab in sensitized kidney transplant recipients.
    Green H; Nesher E; Aizner S; Israeli M; Klein T; Zakai H; Rahamimov R; Rozen-Zvi B; Mor E
    Clin Transplant; 2019 Jun; 33(6):e13562. PubMed ID: 30941818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of urgent desensitization in sensitized heart transplant recipients.
    Fu HY; Wang YC; Tsao CI; Yu SH; Chen YS; Chou HW; Chi NH; Wang CH; Hsu RB; Huang SC; Yu HY; Chou NK
    J Formos Med Assoc; 2022 May; 121(5):969-977. PubMed ID: 34340891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Heart Transplantation After Desensitization in a Patient With Extremely High Panel-Reactive Antibody Levels and Pretransplant Donor-Specific Antibody: A Case Report.
    Nakamura Y; Yoshioka D; Miyagawa S; Yoshikawa Y; Hata H; Matsuura R; Toda K; Sawa Y
    Transplant Proc; 2018 Dec; 50(10):4067-4070. PubMed ID: 30577317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA: The Necker High-Risk Transplant Program.
    Amrouche L; Aubert O; Suberbielle C; Rabant M; Van Huyen JD; Martinez F; Sberro-Soussan R; Scemla A; Tinel C; Snanoudj R; Zuber J; Cavalcanti R; Timsit MO; Lamhaut L; Anglicheau D; Loupy A; Legendre C
    Transplantation; 2017 Oct; 101(10):2440-2448. PubMed ID: 28114171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant DSA monitoring may predict antibody-mediated rejection in sensitized kidney transplant recipients.
    Mohamed MA; Muth B; Vidyasagar V; Foley D; Fernandez L; Hofmann RM; Mezrich J; Pirsch J; Odorico J; d'Alessandro T; Bellingham J; Torrealba J; Kaufman D; Djamali A
    Clin Transpl; 2011; ():389-94. PubMed ID: 22755436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody-Low Titers.
    Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Avila Bernabeu A; Crespo Albiach J; Molina Vila P; Beltrán Catalan S; Pallardó Mateu L
    Transplant Proc; 2016 Nov; 48(9):2880-2883. PubMed ID: 27932097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly Sensitized Patients: Miami Transplant Institute Experience.
    Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
    Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.